img

Global Human Interleukin-2 for Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Interleukin-2 for Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Interleukin-2 is ia type of medication called a biologic response modifier. It is a type of protein called a cytokine that works to increase the production and function of some parts of your body's immune system.
Human Interleukin-2 for Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Interleukin-2 for Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Human Interleukin-2 for Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Human Interleukin-2 for Injection key manufacturers include Clinigen, 3SBio, Beijing Four Rings Biopharmaceutical, Jiangsu Kingsley Pharmaceutical, Beijing Yuance Pharmaceutical, Beijing SL Pharm, Shanghai Huaxin Biotechnology, Changchun Institute Of Biological Products and Shandong Quangang Pharmaceutical, etc. Clinigen, 3SBio, Beijing Four Rings Biopharmaceutical are top 3 players and held % sales share in total in 2022.
Human Interleukin-2 for Injection can be divided into 50000 IU, 100000 IU, 200000 IU and 500000 IU, etc. 50000 IU is the mainstream product in the market, accounting for % sales share globally in 2022.
Human Interleukin-2 for Injection is widely used in various fields, such as Hospital and Pharmacy, etc. Hospital provides greatest supports to the Human Interleukin-2 for Injection industry development. In 2022, global % sales of Human Interleukin-2 for Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Interleukin-2 for Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Clinigen
3SBio
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute Of Biological Products
Shandong Quangang Pharmaceutical
Segment by Type
50000 IU
100000 IU
200000 IU
500000 IU
1 Million IU

Segment by Application


Hospital
Pharmacy

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Interleukin-2 for Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Interleukin-2 for Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Interleukin-2 for Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Human Interleukin-2 for Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Interleukin-2 for Injection introduction, etc. Human Interleukin-2 for Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Human Interleukin-2 for Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Human Interleukin-2 for Injection Market Overview
1.1 Human Interleukin-2 for Injection Product Overview
1.2 Human Interleukin-2 for Injection Market Segment by Type
1.2.1 50000 IU
1.2.2 100000 IU
1.2.3 200000 IU
1.2.4 500000 IU
1.2.5 1 Million IU
1.3 Global Human Interleukin-2 for Injection Market Size by Type
1.3.1 Global Human Interleukin-2 for Injection Market Size Overview by Type (2024-2034)
1.3.2 Global Human Interleukin-2 for Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global Human Interleukin-2 for Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Interleukin-2 for Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe Human Interleukin-2 for Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Human Interleukin-2 for Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Human Interleukin-2 for Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Human Interleukin-2 for Injection Sales Breakdown by Type (2024-2024)
2 Global Human Interleukin-2 for Injection Market Competition by Company
2.1 Global Top Players by Human Interleukin-2 for Injection Sales (2024-2024)
2.2 Global Top Players by Human Interleukin-2 for Injection Revenue (2024-2024)
2.3 Global Top Players by Human Interleukin-2 for Injection Price (2024-2024)
2.4 Global Top Manufacturers Human Interleukin-2 for Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Interleukin-2 for Injection Market Competitive Situation and Trends
2.5.1 Human Interleukin-2 for Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Interleukin-2 for Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Interleukin-2 for Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Human Interleukin-2 for Injection Market
2.8 Key Manufacturers Human Interleukin-2 for Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Interleukin-2 for Injection Status and Outlook by Region
3.1 Global Human Interleukin-2 for Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Human Interleukin-2 for Injection Historic Market Size by Region
3.2.1 Global Human Interleukin-2 for Injection Sales in Volume by Region (2024-2024)
3.2.2 Global Human Interleukin-2 for Injection Sales in Value by Region (2024-2024)
3.2.3 Global Human Interleukin-2 for Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Human Interleukin-2 for Injection Forecasted Market Size by Region
3.3.1 Global Human Interleukin-2 for Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Human Interleukin-2 for Injection Sales in Value by Region (2024-2034)
3.3.3 Global Human Interleukin-2 for Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Interleukin-2 for Injection by Application
4.1 Human Interleukin-2 for Injection Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Human Interleukin-2 for Injection Market Size by Application
4.2.1 Global Human Interleukin-2 for Injection Market Size Overview by Application (2024-2034)
4.2.2 Global Human Interleukin-2 for Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global Human Interleukin-2 for Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Interleukin-2 for Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe Human Interleukin-2 for Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Human Interleukin-2 for Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Human Interleukin-2 for Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Human Interleukin-2 for Injection Sales Breakdown by Application (2024-2024)
5 North America Human Interleukin-2 for Injection by Country
5.1 North America Human Interleukin-2 for Injection Historic Market Size by Country
5.1.1 North America Human Interleukin-2 for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Human Interleukin-2 for Injection Sales in Volume by Country (2024-2024)
5.1.3 North America Human Interleukin-2 for Injection Sales in Value by Country (2024-2024)
5.2 North America Human Interleukin-2 for Injection Forecasted Market Size by Country
5.2.1 North America Human Interleukin-2 for Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Human Interleukin-2 for Injection Sales in Value by Country (2024-2034)
6 Europe Human Interleukin-2 for Injection by Country
6.1 Europe Human Interleukin-2 for Injection Historic Market Size by Country
6.1.1 Europe Human Interleukin-2 for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Human Interleukin-2 for Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe Human Interleukin-2 for Injection Sales in Value by Country (2024-2024)
6.2 Europe Human Interleukin-2 for Injection Forecasted Market Size by Country
6.2.1 Europe Human Interleukin-2 for Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Interleukin-2 for Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Interleukin-2 for Injection by Region
7.1 Asia-Pacific Human Interleukin-2 for Injection Historic Market Size by Region
7.1.1 Asia-Pacific Human Interleukin-2 for Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Interleukin-2 for Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Human Interleukin-2 for Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Human Interleukin-2 for Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Interleukin-2 for Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Interleukin-2 for Injection Sales in Value by Region (2024-2034)
8 Latin America Human Interleukin-2 for Injection by Country
8.1 Latin America Human Interleukin-2 for Injection Historic Market Size by Country
8.1.1 Latin America Human Interleukin-2 for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Human Interleukin-2 for Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America Human Interleukin-2 for Injection Sales in Value by Country (2024-2024)
8.2 Latin America Human Interleukin-2 for Injection Forecasted Market Size by Country
8.2.1 Latin America Human Interleukin-2 for Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Interleukin-2 for Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Interleukin-2 for Injection by Country
9.1 Middle East and Africa Human Interleukin-2 for Injection Historic Market Size by Country
9.1.1 Middle East and Africa Human Interleukin-2 for Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Interleukin-2 for Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Human Interleukin-2 for Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Human Interleukin-2 for Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Interleukin-2 for Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Interleukin-2 for Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Clinigen
10.1.1 Clinigen Company Information
10.1.2 Clinigen Introduction and Business Overview
10.1.3 Clinigen Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Clinigen Human Interleukin-2 for Injection Products Offered
10.1.5 Clinigen Recent Development
10.2 3SBio
10.2.1 3SBio Company Information
10.2.2 3SBio Introduction and Business Overview
10.2.3 3SBio Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 3SBio Human Interleukin-2 for Injection Products Offered
10.2.5 3SBio Recent Development
10.3 Beijing Four Rings Biopharmaceutical
10.3.1 Beijing Four Rings Biopharmaceutical Company Information
10.3.2 Beijing Four Rings Biopharmaceutical Introduction and Business Overview
10.3.3 Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Products Offered
10.3.5 Beijing Four Rings Biopharmaceutical Recent Development
10.4 Jiangsu Kingsley Pharmaceutical
10.4.1 Jiangsu Kingsley Pharmaceutical Company Information
10.4.2 Jiangsu Kingsley Pharmaceutical Introduction and Business Overview
10.4.3 Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Products Offered
10.4.5 Jiangsu Kingsley Pharmaceutical Recent Development
10.5 Beijing Yuance Pharmaceutical
10.5.1 Beijing Yuance Pharmaceutical Company Information
10.5.2 Beijing Yuance Pharmaceutical Introduction and Business Overview
10.5.3 Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Products Offered
10.5.5 Beijing Yuance Pharmaceutical Recent Development
10.6 Beijing SL Pharm
10.6.1 Beijing SL Pharm Company Information
10.6.2 Beijing SL Pharm Introduction and Business Overview
10.6.3 Beijing SL Pharm Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Beijing SL Pharm Human Interleukin-2 for Injection Products Offered
10.6.5 Beijing SL Pharm Recent Development
10.7 Shanghai Huaxin Biotechnology
10.7.1 Shanghai Huaxin Biotechnology Company Information
10.7.2 Shanghai Huaxin Biotechnology Introduction and Business Overview
10.7.3 Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Products Offered
10.7.5 Shanghai Huaxin Biotechnology Recent Development
10.8 Changchun Institute Of Biological Products
10.8.1 Changchun Institute Of Biological Products Company Information
10.8.2 Changchun Institute Of Biological Products Introduction and Business Overview
10.8.3 Changchun Institute Of Biological Products Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Changchun Institute Of Biological Products Human Interleukin-2 for Injection Products Offered
10.8.5 Changchun Institute Of Biological Products Recent Development
10.9 Shandong Quangang Pharmaceutical
10.9.1 Shandong Quangang Pharmaceutical Company Information
10.9.2 Shandong Quangang Pharmaceutical Introduction and Business Overview
10.9.3 Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Products Offered
10.9.5 Shandong Quangang Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Interleukin-2 for Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Interleukin-2 for Injection Industrial Chain Analysis
11.4 Human Interleukin-2 for Injection Market Dynamics
11.4.1 Human Interleukin-2 for Injection Industry Trends
11.4.2 Human Interleukin-2 for Injection Market Drivers
11.4.3 Human Interleukin-2 for Injection Market Challenges
11.4.4 Human Interleukin-2 for Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Interleukin-2 for Injection Distributors
12.3 Human Interleukin-2 for Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 50000 IU
Table 2. Major Company of 100000 IU
Table 3. Major Company of 200000 IU
Table 4. Major Company of 500000 IU
Table 5. Major Company of 1 Million IU
Table 6. Global Human Interleukin-2 for Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Human Interleukin-2 for Injection Sales by Type (2024-2024) & (K Units)
Table 8. Global Human Interleukin-2 for Injection Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Human Interleukin-2 for Injection Sales by Type (2024-2024) & (US& Million)
Table 10. Global Human Interleukin-2 for Injection Market Share in Value by Type (2024-2024)
Table 11. Global Human Interleukin-2 for Injection Price by Type (2024-2024) & (US$/Unit)
Table 12. Global Human Interleukin-2 for Injection Sales by Type (2024-2034) & (K Units)
Table 13. Global Human Interleukin-2 for Injection Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Human Interleukin-2 for Injection Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Human Interleukin-2 for Injection Sales Market Share in Value by Type (2024-2034)
Table 16. Global Human Interleukin-2 for Injection Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Human Interleukin-2 for Injection Sales by Type (2024-2024) & (K Units)
Table 18. North America Human Interleukin-2 for Injection Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Human Interleukin-2 for Injection Sales (K Units) by Type (2024-2024)
Table 20. Europe Human Interleukin-2 for Injection Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Human Interleukin-2 for Injection Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Human Interleukin-2 for Injection Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Human Interleukin-2 for Injection Sales (K Units) by Type (2024-2024)
Table 24. Latin America Human Interleukin-2 for Injection Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Human Interleukin-2 for Injection Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Human Interleukin-2 for Injection Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Human Interleukin-2 for Injection Sales by Company (2024-2024) & (K Units)
Table 28. Global Human Interleukin-2 for Injection Sales Share by Company (2024-2024)
Table 29. Global Human Interleukin-2 for Injection Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Human Interleukin-2 for Injection Revenue Share by Company (2024-2024)
Table 31. Global Market Human Interleukin-2 for Injection Price by Company (2024-2024) & (US$/Unit)
Table 32. Global Human Interleukin-2 for Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Human Interleukin-2 for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Interleukin-2 for Injection as of 2022)
Table 35. Date of Key Manufacturers Enter into Human Interleukin-2 for Injection Market
Table 36. Key Manufacturers Human Interleukin-2 for Injection Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Human Interleukin-2 for Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Human Interleukin-2 for Injection Sales by Region (2024-2024) & (K Units)
Table 40. Global Human Interleukin-2 for Injection Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Human Interleukin-2 for Injection Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Human Interleukin-2 for Injection Sales Market Share in Value by Region (2024-2024)
Table 43. Global Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 44. Global Human Interleukin-2 for Injection Sales by Region (2024-2034) & (K Units)
Table 45. Global Human Interleukin-2 for Injection Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Human Interleukin-2 for Injection Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Human Interleukin-2 for Injection Sales Market Share in Value by Region (2024-2034)
Table 48. Global Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Human Interleukin-2 for Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Human Interleukin-2 for Injection Sales by Application (2024-2024) & (K Units)
Table 51. Global Human Interleukin-2 for Injection Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Human Interleukin-2 for Injection Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Human Interleukin-2 for Injection Sales Market Share in Value by Application (2024-2024)
Table 54. Global Human Interleukin-2 for Injection Price by Application (2024-2024) & (US$/Unit)
Table 55. Global Human Interleukin-2 for Injection Sales by Application (2024-2034) & (K Units)
Table 56. Global Human Interleukin-2 for Injection Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Human Interleukin-2 for Injection Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Human Interleukin-2 for Injection Sales Market Share in Value by Application (2024-2034)
Table 59. Global Human Interleukin-2 for Injection Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Human Interleukin-2 for Injection Sales by Application (2024-2024) (K Units)
Table 61. North America Human Interleukin-2 for Injection Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Human Interleukin-2 for Injection Sales by Application (2024-2024) (K Units)
Table 63. Europe Human Interleukin-2 for Injection Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Human Interleukin-2 for Injection Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Human Interleukin-2 for Injection Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Human Interleukin-2 for Injection Sales by Application (2024-2024) (K Units)
Table 67. Latin America Human Interleukin-2 for Injection Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Human Interleukin-2 for Injection Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Human Interleukin-2 for Injection Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Human Interleukin-2 for Injection Sales by Country (2024-2024) & (K Units)
Table 71. North America Human Interleukin-2 for Injection Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Human Interleukin-2 for Injection Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Human Interleukin-2 for Injection Sales Market Share in Value by Country (2024-2024)
Table 74. North America Human Interleukin-2 for Injection Sales by Country (2024-2034) & (K Units)
Table 75. North America Human Interleukin-2 for Injection Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Human Interleukin-2 for Injection Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Human Interleukin-2 for Injection Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Human Interleukin-2 for Injection Sales by Country (2024-2024) & (K Units)
Table 79. Europe Human Interleukin-2 for Injection Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Human Interleukin-2 for Injection Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Human Interleukin-2 for Injection Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Human Interleukin-2 for Injection Sales by Country (2024-2034) & (K Units)
Table 83. Europe Human Interleukin-2 for Injection Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Human Interleukin-2 for Injection Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Human Interleukin-2 for Injection Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Human Interleukin-2 for Injection Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Human Interleukin-2 for Injection Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Human Interleukin-2 for Injection Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Human Interleukin-2 for Injection Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Human Interleukin-2 for Injection Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Human Interleukin-2 for Injection Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Human Interleukin-2 for Injection Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Human Interleukin-2 for Injection Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Human Interleukin-2 for Injection Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Human Interleukin-2 for Injection Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Human Interleukin-2 for Injection Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Human Interleukin-2 for Injection Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Human Interleukin-2 for Injection Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Human Interleukin-2 for Injection Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Human Interleukin-2 for Injection Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Human Interleukin-2 for Injection Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Human Interleukin-2 for Injection Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Human Interleukin-2 for Injection Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Human Interleukin-2 for Injection Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Human Interleukin-2 for Injection Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Human Interleukin-2 for Injection Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Human Interleukin-2 for Injection Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Human Interleukin-2 for Injection Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Human Interleukin-2 for Injection Sales Market Share in Value by Country (2024-2034)
Table 110. Clinigen Company Information
Table 111. Clinigen Introduction and Business Overview
Table 112. Clinigen Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Clinigen Human Interleukin-2 for Injection Product
Table 114. Clinigen Recent Development
Table 115. 3SBio Company Information
Table 116. 3SBio Introduction and Business Overview
Table 117. 3SBio Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. 3SBio Human Interleukin-2 for Injection Product
Table 119. 3SBio Recent Development
Table 120. Beijing Four Rings Biopharmaceutical Company Information
Table 121. Beijing Four Rings Biopharmaceutical Introduction and Business Overview
Table 122. Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Product
Table 124. Beijing Four Rings Biopharmaceutical Recent Development
Table 125. Jiangsu Kingsley Pharmaceutical Company Information
Table 126. Jiangsu Kingsley Pharmaceutical Introduction and Business Overview
Table 127. Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Product
Table 129. Jiangsu Kingsley Pharmaceutical Recent Development
Table 130. Beijing Yuance Pharmaceutical Company Information
Table 131. Beijing Yuance Pharmaceutical Introduction and Business Overview
Table 132. Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Product
Table 134. Beijing Yuance Pharmaceutical Recent Development
Table 135. Beijing SL Pharm Company Information
Table 136. Beijing SL Pharm Introduction and Business Overview
Table 137. Beijing SL Pharm Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Beijing SL Pharm Human Interleukin-2 for Injection Product
Table 139. Beijing SL Pharm Recent Development
Table 140. Shanghai Huaxin Biotechnology Company Information
Table 141. Shanghai Huaxin Biotechnology Introduction and Business Overview
Table 142. Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Product
Table 144. Shanghai Huaxin Biotechnology Recent Development
Table 145. Changchun Institute Of Biological Products Company Information
Table 146. Changchun Institute Of Biological Products Introduction and Business Overview
Table 147. Changchun Institute Of Biological Products Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Changchun Institute Of Biological Products Human Interleukin-2 for Injection Product
Table 149. Changchun Institute Of Biological Products Recent Development
Table 150. Shandong Quangang Pharmaceutical Company Information
Table 151. Shandong Quangang Pharmaceutical Introduction and Business Overview
Table 152. Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Product
Table 154. Shandong Quangang Pharmaceutical Recent Development
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Human Interleukin-2 for Injection Market Trends
Table 158. Human Interleukin-2 for Injection Market Drivers
Table 159. Human Interleukin-2 for Injection Market Challenges
Table 160. Human Interleukin-2 for Injection Market Restraints
Table 161. Human Interleukin-2 for Injection Distributors List
Table 162. Human Interleukin-2 for Injection Downstream Customers
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Interleukin-2 for Injection Product Picture
Figure 2. Global Human Interleukin-2 for Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Interleukin-2 for Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Human Interleukin-2 for Injection Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of 50000 IU
Figure 6. Global 50000 IU Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of 100000 IU
Figure 8. Global 100000 IU Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of 200000 IU
Figure 10. Global 200000 IU Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of 500000 IU
Figure 12. Global 500000 IU Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of 1 Million IU
Figure 14. Global 1 Million IU Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Human Interleukin-2 for Injection Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Human Interleukin-2 for Injection Sales Market Share by Type in 2022 & 2034
Figure 17. North America Human Interleukin-2 for Injection Sales Market Share in Volume by Type in 2022
Figure 18. North America Human Interleukin-2 for Injection Sales Market Share in Value by Type in 2022
Figure 19. Europe Human Interleukin-2 for Injection Sales Market Share in Volume by Type in 2022
Figure 20. Europe Human Interleukin-2 for Injection Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Human Interleukin-2 for Injection Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Human Interleukin-2 for Injection Sales Market Share in Value by Type in 2022
Figure 23. Latin America Human Interleukin-2 for Injection Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Human Interleukin-2 for Injection Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Human Interleukin-2 for Injection Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Human Interleukin-2 for Injection Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Interleukin-2 for Injection Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Interleukin-2 for Injection Revenue in 2022
Figure 29. Human Interleukin-2 for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Pharmacy
Figure 33. Global Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Human Interleukin-2 for Injection Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Human Interleukin-2 for Injection Sales Market Share by Application in 2022 & 2034
Figure 36. North America Human Interleukin-2 for Injection Sales Market Share in Volume by Application in 2022
Figure 37. North America Human Interleukin-2 for Injection Sales Market Share in Value by Application in 2022
Figure 38. Europe Human Interleukin-2 for Injection Sales Market Share in Volume by Application in 2022
Figure 39. Europe Human Interleukin-2 for Injection Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Human Interleukin-2 for Injection Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Human Interleukin-2 for Injection Sales Market Share in Value by Application in 2022
Figure 42. Latin America Human Interleukin-2 for Injection Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Human Interleukin-2 for Injection Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Human Interleukin-2 for Injection Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Human Interleukin-2 for Injection Manufacturing Cost Structure
Figure 47. Human Interleukin-2 for Injection Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed